EDGAR Filing Documents for 0001144204-17-062799

Form 8-K - Current report:

SEC Accession No. 0001144204-17-062799

Filing Date

2017-12-07

Accepted

2017-12-07 16:32:18

Documents

Period of Report

2017-12-01

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tv480895_8k.htm	8-K	28342
2	EXHIBIT 3.1	tv480895_ex3-1.htm	EX-3.1	37735
3	EXHIBIT 10.1	tv480895_ex10-1.htm	EX-10.1	53851
4	EXHIBIT 10.2	tv480895_ex10-2.htm	EX-10.2	30699
5	EXHIBIT 10.3	tv480895_ex10-3.htm	EX-10.3	58288
6	EXHIBIT 99.1	tv480895_ex99-1.htm	EX-99.1	11144
7	GRAPHIC	tv480895_ex99-1img1.jpg	GRAPHIC	10703
8	GRAPHIC	tv480895_ex10-1img1.jpg	GRAPHIC	2255
	Complete submission text file	0001144204-17-062799.txt		239576

Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814

Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024

NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)